NEVVI Medicare utilization intelligence

← back

CHAUDHRY, BAREIAD.O. NPI 1407219728 Clinician

Hematology-Oncology · STONY BROOK, NY

Specialty Hematology-Oncology — from billed Medicare claims
Trained STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 7 years since medical school (class of 2019, self-reported to CMS)
Location STONY BROOK, NY · NPPES registered location
Active in data Billed Medicare 2022–2024 (3 consecutive years)
Scale 71 codes billed · 68,883 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20232026
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
2025–2026
HUDSON VALLEY HEMATOLOGY ONCOLOGY ASSOCIATES, RLLP
2023–2024

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2023-04

Year: 2024 · 2023 · 2022 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1100 Injection, dexamethasone sodium phosphate, 1 mg
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
83615 Lactate dehydrogenase (enzyme) level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
82728 Ferritin (blood protein) level
88185 Flow cytometry technique for dna or cell analysis, each additional marker
83540 Iron level
83550 Iron binding capacity
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
82784 Gammaglobulin (immune system protein) measurement
84100 Phosphate level
83735 Magnesium level
84550 Uric acid level, blood
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96372 Injection of drug or substance under skin or into muscle
96413 Administration of chemotherapy into vein, 1 hour or less
85044 Red blood count, manual test
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
82378 Carcinoembryonic antigen (cea) protein level
83521 Measurement of immunoglobulin light chains
84165 Protein measurement, serum
86334 Immunologic analysis technique on serum (immunofixation)
82232 Beta-2 microglobulin (protein) level
96375 Injection of additional new drug or substance into vein
85610 Blood test, clotting time
84443 Blood test, thyroid stimulating hormone (tsh)
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
83883 Nephelometry, test method using light
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
84466 Transferrin (iron binding protein) level
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
84439 Thyroxine (thyroid chemical), free
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
86141 Measurement c-reactive protein for detection of infection or inflammation, high sensitivity
96415 Administration of chemotherapy into vein, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
82533 Cortisol (hormone) measurement, total
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96374 Injection of drug or substance into vein
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
99195 Drawing of blood for a medical problem
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
99442 Telephone medical discussion with physician, 11-20 minutes
96361 Infusion into a vein for hydration, each additional hour
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
86140 Measurement c-reactive protein for detection of infection or inflammation
J7050 Infusion, normal saline solution, 250 cc
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
88184 Flow cytometry technique for dna or cell analysis, first marker
82306 Vitamin d-3 level
71260 Ct scan of chest with contrast
83010 Haptoglobin (serum protein) level
84480 Thyroid hormone, t3 measurement, total
74177 Ct scan of abdomen and pelvis with contrast
82785 Ige (immune system protein) level

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.